Generalized pustulosis and severe tubulointerstitial nephropathy as manifestations of carbamazepine hypersensitivity syndrome.
Moreno-Ramírez
David
D
García-Bravo
Begona
B
Rodríguez-Pichardo
Antonio
A
Camacho
Clotilde Ríos
CR
Martínez
Francisco Camacho
FC
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003875:Drug Eruptions / Q000150:complications / Q000175:diagnosis / Q000209:etiology*; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009395:Nephritis, Interstitial / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D006435:Renal Dialysis; D018570:Risk Assessment; D012720:Severity of Illness Index; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D016896:Treatment Outcome
D000927:Anticonvulsants; D002220:Carbamazepine